Sectors & Industries HealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2025)
Top pharmaceutical stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best pharmaceutical stocks to buy now. Learn More.

Industry: Drug Manufacturers - Spec...

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Pharmaceutical is Zen Rated B and is the 39th ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
IRWD	IRONWOOD PHARMACEUTICALS INC	$3.13	-3.99%	-12.57%	-1.57%	121.99%	345.87%	-19.33%	-73.74%	-74.24%	-72.97%	$4.78	$0.53	34.45%	493.93%	0.67	5,338,000	63.99%
COLL	COLLEGIUM PHARMACEUTICAL INC	$48.88	-0.91%	0.51%	9.92%	36.73%	63.86%	60.58%	114.57%	165.94%	102.07%	$49.92	$23.23	2.08%	110.42%	0.59	870,000	26.09%
INDV	INDIVIOR PLC	$35.21	-0.93%	-0.98%	8.01%	56.42%	151.32%	205.11%	N/A	N/A	N/A	$38.00	$7.62	7.34%	362.07%	0.80	22,632,000	1,007.78%
NBIX	NEUROCRINE BIOSCIENCES INC	$145.00	2.23%	-5.10%	5.03%	-0.16%	14.58%	7.44%	22.95%	44.58%	182.16%	$160.18	$84.23	9.48%	72.15%	0.63	1,984,000	30.44%
AMRX	AMNEAL PHARMACEUTICALS INC	$12.57	-0.55%	2.95%	9.11%	28.13%	60.74%	62.19%	481.94%	190.30%	N/A	$12.82	$6.69	1.95%	88.03%	1.08	2,762,000	-12.87%
PAHC	PHIBRO ANIMAL HEALTH CORP	$37.25	-7.82%	-7.22%	-9.98%	-6.55%	55.99%	70.79%	192.62%	97.19%	16.99%	$46.42	$16.16	19.75%	130.51%	0.88	832,000	186.90%
BHC	BAUSCH HEALTH COMPANIES INC	$6.88	0.88%	-0.58%	13.72%	2.23%	11.33%	-6.90%	-1.71%	-66.75%	-93.67%	$8.68	$4.25	20.74%	61.88%	1.23	2,013,000	67.75%
ANIP	ANI PHARMACEUTICALS INC	$82.85	0.02%	3.06%	3.14%	-14.40%	26.37%	52.69%	117.40%	179.80%	82.81%	$99.50	$52.74	16.73%	57.11%	0.81	965,000	269.73%
SUPN	SUPERNUS PHARMACEUTICALS INC	$51.48	4.46%	9.16%	12.65%	11.82%	59.48%	43.92%	42.84%	129.62%	262.03%	$57.65	$29.16	10.70%	76.54%	0.63	1,620,000	124.38%
KMDA	KAMADA LTD	$7.28	0.83%	3.70%	5.05%	5.35%	1.11%	24.44%	74.16%	13.75%	79.31%	$9.16	$5.54	20.48%	31.41%	0.66	151,000	31.30%
ORGO	ORGANOGENESIS HOLDINGS INC	$5.60	-2.95%	16.18%	9.16%	22.27%	73.37%	80.06%	119.61%	-9.09%	N/A	$7.08	$2.61	20.87%	114.56%	1.68	1,169,000	-34.84%
VTRS	VIATRIS INC	$11.93	-0.08%	2.40%	14.05%	20.51%	34.50%	-1.65%	9.35%	-31.40%	-77.76%	$12.68	$6.85	5.91%	74.16%	0.78	28,943,000	88.81%
PCRX	PACIRA BIOSCIENCES INC	$26.35	1.82%	0.23%	8.30%	-1.16%	8.75%	34.64%	-32.14%	-54.86%	-64.90%	$27.64	$18.17	4.67%	45.02%	0.62	2,544,000	198.59%
EBS	EMERGENT BIOSOLUTIONS INC	$12.42	0.98%	8.85%	25.58%	51.28%	99.68%	54.09%	11.29%	-86.76%	-67.63%	$13.41	$4.02	7.38%	208.96%	1.75	1,806,000	147.40%
ELAN	ELANCO ANIMAL HEALTH INC	$22.30	0.95%	4.74%	3.91%	16.15%	65.68%	88.66%	88.19%	-24.48%	N/A	$23.70	$8.02	5.91%	178.05%	1.17	19,383,000	472.45%
TEVA	TEVA PHARMACEUTICAL INDUSTRIES LTD	$30.35	0.10%	1.88%	24.18%	65.40%	79.06%	42.42%	254.14%	210.01%	-53.95%	$30.56	$12.47	0.69%	143.48%	0.91	10,759,000	67.79%
ALKS	ALKERMES PLC	$28.45	2.30%	-0.18%	-0.84%	2.37%	-2.20%	-5.07%	12.72%	30.50%	-63.28%	$36.45	$25.17	21.95%	13.05%	0.59	4,281,000	185.02%
ASRT	ASSERTIO HOLDINGS INC	$0.72	1.12%	-5.51%	-3.87%	-20.35%	14.47%	-14.59%	-79.60%	-49.40%	-99.02%	$1.01	$0.51	28.71%	40.08%	1.32	465,000	48.56%
DVAX	DYNAVAX TECHNOLOGIES CORP	$10.86	-0.09%	0.56%	-1.72%	12.07%	8.71%	-14.89%	-0.64%	107.65%	-59.85%	$14.63	$9.20	25.77%	18.04%	1.13	3,960,000	245.85%
HCM	HUTCHMED (CHINA) LTD	$13.55	1.50%	0.97%	-6.74%	-20.48%	-8.69%	-7.26%	3.36%	-53.02%	N/A	$19.50	$11.51	30.51%	17.77%	1.15	71,000	454.69%
ETON	ETON PHARMACEUTICALS INC	$16.37	2.18%	-1.98%	-2.68%	-10.74%	20.63%	33.31%	436.72%	86.02%	N/A	$23.00	$11.09	28.83%	47.65%	0.85	272,000	77.78%
AMPH	AMPHASTAR PHARMACEUTICALS INC	$26.60	0.38%	5.26%	4.85%	-3.76%	8.31%	-32.47%	-5.81%	41.34%	85.75%	$39.77	$20.39	33.12%	30.49%	0.58	812,000	138.12%
ESPR	ESPERION THERAPEUTICS INC	$3.93	3.42%	2.08%	40.86%	47.74%	267.29%	80.69%	-33.39%	-86.27%	-82.60%	$4.13	$0.69	4.84%	467.10%	1.00	12,481,000	201.76%
HLN	HALEON PLC	$9.90	0.61%	3.99%	4.10%	8.08%	-4.90%	2.06%	29.75%	N/A	N/A	$11.42	$8.71	13.31%	13.66%	0.31	9,340,000	44.96%
PRGO	PERRIGO CO PLC	$13.23	-0.60%	0.68%	3.20%	-37.77%	-50.08%	-48.58%	-57.49%	-70.48%	-90.83%	$30.93	$12.17	57.23%	8.71%	0.57	4,721,000	38.65%
DERM	JOURNEY MEDICAL CORP	$7.87	-0.63%	2.61%	2.88%	7.81%	20.89%	69.25%	505.38%	N/A	N/A	$9.40	$3.54	16.28%	122.63%	0.54	401,000	317.71%
TKNO	ALPHA TEKNOVA INC	$4.65	0.00%	-1.27%	5.20%	0.22%	-16.37%	-35.77%	0.87%	N/A	N/A	$10.37	$3.94	55.16%	18.02%	1.37	207,000	132.58%
PBH	PRESTIGE CONSUMER HEALTHCARE INC	$61.74	-0.32%	0.49%	5.56%	-2.16%	-26.01%	-21.51%	0.62%	76.91%	18.94%	$90.04	$57.25	31.43%	7.84%	0.46	1,326,000	223.41%
LFCR	LIFECORE BIOMEDICAL INC	$8.04	-4.51%	3.21%	7.34%	2.16%	15.85%	13.72%	19.82%	-23.50%	-32.72%	$8.85	$4.76	9.15%	68.91%	1.13	328,000	36.10%
ZTS	ZOETIS INC	$122.24	-0.42%	3.02%	4.41%	-16.21%	-22.22%	-25.24%	-14.63%	-24.00%	158.22%	$177.40	$115.25	31.09%	6.07%	0.84	11,298,000	42.47%
CTOR	CITIUS ONCOLOGY INC	$1.39	21.93%	23.01%	14.88%	-21.02%	-47.15%	31.13%	-86.31%	N/A	N/A	$6.19	$0.55	77.54%	152.27%	-0.39	2,657,000	132.66%
EOLS	EVOLUS INC	$7.07	-1.53%	0.43%	4.28%	12.40%	-23.81%	-34.96%	1.00%	72.44%	N/A	$17.12	$5.71	58.70%	23.82%	1.05	1,688,000	172.26%
SCYX	SCYNEXIS INC	$0.63	-0.48%	-2.94%	6.27%	-44.02%	-14.58%	-37.92%	-65.07%	-89.88%	-98.91%	$1.49	$0.57	57.92%	10.97%	1.24	235,000	-54.37%
SIGA	SIGA TECHNOLOGIES INC	$6.27	-0.63%	-2.94%	6.09%	-28.59%	2.45%	3.98%	-17.82%	-12.18%	795.71%	$9.62	$4.95	34.82%	26.67%	0.92	530,000	54.07%
HROW	HARROW INC	$46.40	4.13%	-1.40%	17.17%	4.65%	51.34%	34.77%	286.99%	788.89%	551.69%	$51.30	$20.85	9.55%	122.54%	1.02	665,000	69.64%
TAK	TAKEDA PHARMACEUTICAL CO LTD	$14.90	0.47%	3.98%	5.75%	-1.06%	0.88%	14.53%	-0.40%	-19.89%	-39.48%	$15.69	$12.80	5.04%	16.41%	0.34	5,065,000	4.26%
CRON	CRONOS GROUP INC	$2.96	-0.34%	-9.48%	25.42%	12.98%	59.14%	58.29%	8.82%	-60.37%	N/A	$3.43	$1.60	13.70%	85.00%	1.19	3,437,000	-53.18%
LNTH	LANTHEUS HOLDINGS INC	$65.92	1.67%	-1.05%	24.87%	30.77%	-16.76%	-28.30%	25.83%	342.12%	1,816.28%	$111.29	$47.25	40.77%	39.51%	0.91	2,734,000	165.18%
RGC	REGENCELL BIOSCIENCE HOLDINGS LTD	$19.81	4.70%	19.34%	53.92%	26.66%	-47.88%	14,255.07%	2,417.15%	N/A	N/A	$83.60	$0.09	76.30%	21,201.08%	0.33	289,000	-22.10%
TLRY	TILRAY BRANDS INC	$11.16	-9.56%	-8.15%	16.01%	-7.77%	210.00%	-3.79%	-62.55%	-86.70%	N/A	$23.20	$3.51	51.90%	218.22%	1.67	22,555,000	-66.80%
YCBD	CBDMD INC	$1.51	-21.76%	25.83%	183.30%	129.48%	84.15%	-48.99%	-98.50%	-99.86%	N/A	$6.54	$0.47	76.90%	221.28%	0.80	15,953,000	-69.98%
RDY	DR REDDYS LABORATORIES LTD	$14.18	1.72%	1.14%	0.93%	-4.64%	-6.89%	-6.22%	34.15%	3.99%	56.10%	$16.17	$12.26	12.31%	15.66%	0.43	1,384,000	-14.25%
OGI	ORGANIGRAM GLOBAL INC	$2.01	-0.99%	4.69%	33.11%	11.67%	55.81%	37.67%	-40.60%	-62.50%	N/A	$2.24	$0.85	10.27%	136.47%	1.54	2,112,000	-61.52%
TLPH	TALPHERA INC	$1.10	-0.90%	-7.56%	-16.67%	29.41%	139.13%	77.99%	-50.00%	-95.60%	-98.73%	$1.57	$0.38	29.94%	189.47%	0.87	1,465,000	70.55%
CGC	CANOPY GROWTH CORP	$1.48	-12.43%	-14.94%	40.95%	8.03%	19.35%	-45.39%	-93.86%	-99.42%	N/A	$3.07	$0.77	51.79%	92.21%	1.87	63,084,000	-70.83%
AQST	AQUESTIVE THERAPEUTICS INC	$5.80	-0.17%	-6.60%	-0.51%	2.29%	78.46%	59.34%	550.95%	-11.59%	N/A	$7.55	$2.12	23.18%	173.58%	1.35	4,614,000	154.36%
QNTM	QUANTUM BIOPHARMA LTD	$8.89	0.79%	-5.22%	40.89%	-52.89%	-74.60%	156.94%	-83.52%	-92.05%	N/A	$38.25	$2.89	76.76%	207.61%	1.16	45,300	-23.22%
BIOA	BIOAGE LABS INC	$13.39	8.16%	3.96%	62.50%	173.27%	208.53%	158.99%	N/A	N/A	N/A	$13.41	$2.88	0.13%	364.93%	0.91	1,151,000	546.63%
FLGC	FLORA GROWTH CORP	$7.31	-4.19%	-24.95%	-4.44%	-73.13%	-71.55%	-81.44%	-96.37%	N/A	N/A	$47.00	$6.80	84.45%	7.50%	1.63	97,000	-2.02%
EVO	EVOTEC SE	$2.95	0.68%	-1.99%	-1.34%	-18.96%	-21.54%	-32.95%	-63.85%	N/A	N/A	$5.10	$2.84	42.16%	3.87%	1.06	2,047,000	537.69%
AKAN	AKANDA CORP	$0.61	-10.36%	-34.68%	-33.48%	-82.56%	-84.65%	-85.55%	-99.83%	N/A	N/A	$9.29	$0.59	93.39%	3.89%	1.14	4,472,000	-63.11%
ALVO	ALVOTECH	$4.90	3.59%	-12.03%	-6.31%	-37.82%	-47.59%	-59.54%	-37.48%	-52.75%	N/A	$13.70	$4.32	64.23%	13.43%	0.34	913,000	1.44%
RMTI	ROCKWELL MEDICAL INC	$0.85	-0.12%	-8.22%	-1.28%	-36.17%	-4.61%	-58.59%	-14.33%	-92.28%	-99.23%	$2.41	$0.78	64.77%	8.85%	1.38	428,000	97.24%
SHPH	SHUTTLE PHARMACEUTICALS HOLDINGS INC	$1.72	1.18%	-3.91%	-13.13%	-57.95%	-54.74%	-89.88%	-99.62%	N/A	N/A	$25.25	$1.26	93.19%	36.51%	0.50	45,000	-77.61%
KALA	KALA BIO INC	$0.62	7.43%	-7.85%	-1.74%	-96.83%	-84.60%	-89.63%	-84.41%	-99.83%	N/A	$20.60	$0.51	96.98%	21.96%	0.91	2,029,000	18.65%
ACB	AURORA CANNABIS INC	$4.96	-7.81%	-8.15%	15.35%	-2.55%	21.57%	20.98%	-48.52%	-94.45%	-89.07%	$6.91	$3.42	28.22%	44.94%	1.62	4,257,000	-57.81%
CRDL	CARDIOL THERAPEUTICS INC	$1.01	0.00%	-6.48%	1.30%	-9.82%	-18.55%	-22.90%	74.14%	N/A	N/A	$1.59	$0.77	36.48%	31.00%	1.40	277,000	-6.42%
BFRI	BIOFRONTERA INC	$0.77	0.79%	-5.67%	-5.32%	-14.89%	25.16%	-24.90%	-95.21%	N/A	N/A	$1.87	$0.54	59.04%	42.91%	0.97	66,000	-71.91%
GELS	GELTEQ LTD	$0.90	4.30%	-11.19%	-1.64%	-33.56%	-43.94%	-67.02%	N/A	N/A	N/A	$4.11	$0.77	78.18%	16.49%	2.23	47,400	21.54%
IMCC	IM CANNABIS CORP	$1.56	2.63%	-17.02%	16.42%	-19.59%	-43.68%	-22.00%	-81.29%	N/A	N/A	$7.12	$0.93	78.09%	67.74%	0.56	118,000	-73.89%
SNOA	SONOMA PHARMACEUTICALS INC	$3.57	-0.83%	-0.56%	6.89%	-14.59%	17.43%	40.00%	-85.25%	-97.95%	-99.64%	$6.92	$1.75	48.41%	104.00%	1.08	13,000	-30.85%
APUS	APIMEDS PHARMACEUTICALS US INC	$1.52	-14.12%	-28.97%	-49.83%	-24.75%	-6.75%	N/A	N/A	N/A	N/A	$4.03	$1.37	62.29%	10.95%	0.40	151,000	30.17%
SXTC	CHINA SXT PHARMACEUTICALS INC	$1.61	4.55%	14.18%	20.60%	-17.44%	-12.50%	-40.83%	-98.51%	-99.97%	N/A	$7.84	$0.95	79.46%	69.47%	1.86	20,000	6.95%
PRFX	PAINREFORM LTD	$0.88	-0.56%	-8.87%	0.00%	-40.27%	-44.92%	-92.08%	-99.14%	-99.93%	N/A	$6.65	$0.80	86.71%	10.36%	1.00	55,000	45.50%
BGM	BGM GROUP LTD	$4.36	-12.97%	-19.71%	-48.65%	-56.09%	-66.64%	-48.71%	-11.92%	N/A	N/A	$17.17	$4.36	74.61%	0.00%	0.35	52,000	940.00%
TXMD	THERAPEUTICSMD INC	$1.70	1.80%	-2.86%	3.03%	55.96%	55.96%	55.96%	-75.61%	-97.24%	-99.65%	$2.44	$0.70	30.33%	142.86%	0.92	52,000	30.65%
RDHL	REDHILL BIOPHARMA LTD	$1.18	2.61%	-2.07%	13.46%	-30.18%	-37.89%	-81.76%	-99.30%	-99.99%	-99.99%	$7.00	$1.01	83.14%	16.83%	1.10	20,400	-60.77%
UPC	UNIVERSE PHARMACEUTICALS INC	$3.73	2.42%	-6.33%	4.43%	-16.97%	-5.14%	-85.32%	-99.93%	N/A	N/A	$28.00	$2.51	86.69%	48.53%	0.12	11,700	207.89%
SBFM	SUNSHINE BIOPHARMA INC	$1.39	1.83%	3.73%	-1.42%	-5.44%	-3.47%	-50.36%	-99.90%	-99.98%	-100.00%	$3.90	$1.17	64.36%	18.91%	1.10	22,000	-31.89%
ZYBT	ZHENGYE BIOTECHNOLOGY HOLDING LTD	$1.85	0.54%	-7.96%	-13.95%	-79.96%	-80.11%	N/A	N/A	N/A	N/A	$14.30	$1.40	87.06%	32.14%	1.51	8,100	-53.45%
AVDL	AVADEL PHARMACEUTICALS PLC	$21.47	0.23%	0.51%	-7.06%	32.53%	133.88%	112.36%	214.35%	209.81%	56.03%	$23.57	$6.38	8.91%	236.52%	1.03	4,461,000	221.63%
CPHI	CHINA PHARMA HOLDINGS INC	$1.41	-2.08%	-9.27%	-8.44%	-29.15%	-19.43%	-11.54%	-97.59%	-99.34%	-98.41%	$3.35	$1.20	57.91%	17.50%	0.89	8,200	290.48%
IXHL	INCANNEX HEALTHCARE INC	$0.44	10.33%	3.55%	31.53%	-16.57%	100.00%	-75.46%	-96.64%	N/A	N/A	$2.25	$0.08	80.53%	447.50%	0.28	34,874,000	170.66%
CPIX	CUMBERLAND PHARMACEUTICALS INC	$4.41	0.68%	74.31%	129.69%	40.00%	1.38%	90.09%	104.17%	42.26%	-19.53%	$7.25	$1.85	39.17%	138.38%	0.37	324,000	-17.77%
AYTU	AYTU BIOPHARMA INC	$2.55	3.24%	10.87%	27.50%	4.51%	27.50%	84.78%	-41.67%	-97.93%	N/A	$2.82	$0.95	9.57%	168.42%	0.92	134,000	30.10%
INCR	INTERCURE LTD	$1.36	-6.21%	3.03%	1.49%	-6.85%	-10.53%	1.49%	-67.62%	N/A	N/A	$1.79	$1.22	24.02%	11.48%	0.76	132,000	50.00%
CABR	CARING BRANDS INC	$0.99	10.90%	-14.17%	-9.45%	N/A	N/A	N/A	N/A	N/A	N/A	$3.20	$0.71	69.16%	38.82%	8.62	133,000	4.72%

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in Dec 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best pharma stocks to buy right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the #1 top pharmaceutical stock out of 77 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ironwood Pharmaceuticals (NASDAQ:IRWD) is: Value: A, Growth: B, Momentum: B, Sentiment: C, Safety: C, Financials: A, and AI: B.

Ironwood Pharmaceuticals (NASDAQ:IRWD) has a Due Diligence Score of 35, which is 7 points higher than the pharmaceutical industry average of 28.

IRWD passed 11 out of 33 due diligence checks and has average fundamentals. Ironwood Pharmaceuticals has seen its stock lose -19.33% over the past year, underperforming other pharmaceutical stocks by -18 percentage points.

Ironwood Pharmaceuticals has an average 1 year price target of $3.00, a downside of -4.15% from Ironwood Pharmaceuticals's current stock price of $3.13.

Ironwood Pharmaceuticals stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Ironwood Pharmaceuticals, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Collegium Pharmaceutical (NASDAQ:COLL)

Collegium Pharmaceutical (NASDAQ:COLL) is the #2 top pharmaceutical stock out of 77 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Collegium Pharmaceutical (NASDAQ:COLL) is: Value: A, Growth: B, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: A.

Collegium Pharmaceutical (NASDAQ:COLL) has a Due Diligence Score of 49, which is 21 points higher than the pharmaceutical industry average of 28.

COLL passed 17 out of 33 due diligence checks and has strong fundamentals. Collegium Pharmaceutical has seen its stock return 60.58% over the past year, overperforming other pharmaceutical stocks by 61 percentage points.

Collegium Pharmaceutical has an average 1 year price target of $49.50, an upside of 1.27% from Collegium Pharmaceutical's current stock price of $48.88.

Collegium Pharmaceutical stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Collegium Pharmaceutical, 50% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Indivior (NASDAQ:INDV)

Indivior (NASDAQ:INDV) is the #3 top pharmaceutical stock out of 77 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Indivior (NASDAQ:INDV) is: Value: B, Growth: B, Momentum: B, Sentiment: B, Safety: B, Financials: B, and AI: C.

Indivior (NASDAQ:INDV) has a Due Diligence Score of 33, which is 5 points higher than the pharmaceutical industry average of 28.

INDV passed 10 out of 33 due diligence checks and has average fundamentals. Indivior has seen its stock return 205.11% over the past year, overperforming other pharmaceutical stocks by 206 percentage points.

Indivior has an average 1 year price target of $32.50, a downside of -7.7% from Indivior's current stock price of $35.21.

Indivior stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Indivior, 50% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the pharmaceutical stocks with highest dividends?

Out of 6 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Perrigo Co (NYSE:PRGO)

Perrigo Co (NYSE:PRGO) has an annual dividend yield of 4.38%, which is 2 percentage points higher than the pharmaceutical industry average of 2.27%. Perrigo Co's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Perrigo Co's dividend has shown consistent growth over the last 10 years.

Perrigo Co's dividend payout ratio of -301.6% indicates that its high dividend yield might not be sustainable for the long-term.

2. Viatris (NASDAQ:VTRS)

Viatris (NASDAQ:VTRS) has an annual dividend yield of 4.02%, which is 2 percentage points higher than the pharmaceutical industry average of 2.27%. Viatris's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Viatris's dividend has shown consistent growth over the last 10 years.

Viatris's dividend payout ratio of -15.5% indicates that its high dividend yield might not be sustainable for the long-term.

3. Kamada (NASDAQ:KMDA)

Kamada (NASDAQ:KMDA) has an annual dividend yield of 2.75%, which is the same as the pharmaceutical industry average of 2.27%.

Kamada's dividend payout ratio of 57.1% indicates that its dividend yield is sustainable for the long-term.

Why are pharmaceutical stocks up?

Pharmaceutical stocks were up 0.4% in the last day, and up 0.17% over the last week. Hutchmed was the among the top gainers in the drug manufacturers - specialty & generic industry, gaining 1.5% yesterday.

Shares of copper stocks are trading higher following reports suggesting that the metal is experiencing mine supply constraints and a growth in demand.

What are the most undervalued pharmaceutical stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued pharmaceutical stocks right now are:

1. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Bausch Health Companies has a valuation score of 57, which is 34 points higher than the pharmaceutical industry average of 23. It passed 4 out of 7 valuation due diligence checks.

Bausch Health Companies's stock has dropped -6.9% in the past year. It has underperformed other stocks in the pharmaceutical industry by -6 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 57, which is 34 points higher than the pharmaceutical industry average of 23. It passed 4 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has dropped -19.33% in the past year. It has underperformed other stocks in the pharmaceutical industry by -18 percentage points.

3. Alkermes (NASDAQ:ALKS)

Alkermes (NASDAQ:ALKS) is the third most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Alkermes has a valuation score of 57, which is 34 points higher than the pharmaceutical industry average of 23. It passed 4 out of 7 valuation due diligence checks.

Alkermes's stock has dropped -5.07% in the past year. It has underperformed other stocks in the pharmaceutical industry by -4 percentage points.

Are pharmaceutical stocks a good buy now?

52.38% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 51.9% over the next year.

24.56% of pharmaceutical stocks have a Zen Rating of A (Strong Buy), 10.53% of pharmaceutical stocks are rated B (Buy), 49.12% are rated C (Hold), 12.28% are rated D (Sell), and 3.51% are rated F (Strong Sell).

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is -24.72x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.